Following positive trial data , retatrutide, a new peptide treatment for treating adult-onset metabolic disorder, has obtained conditional approval from Great Britain's Drug and Healthcare Agency (MHRA https://teganxlvm163097.full-design.com/retatrutide-medication-peptide-british-authorization-and-availability-83830630